Sofinnova Venture Partners X L.P. 13D and 13G filings for CinCor Pharma, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-03-01 1:38 pm Sale |
2023-02-24 | 13D | CinCor Pharma, Inc. CINC |
Sofinnova Venture Partners X L.P. | 0 0.000% |
-6,109,360 (Position Closed) |
Filing |
| 2022-08-19 5:38 pm Purchase |
2022-08-11 | 13D | CinCor Pharma, Inc. CINC |
Sofinnova Venture Partners X L.P. | 6,109,360 14.300% |
535,411 (+9.61%) |
Filing |
| 2022-01-21 3:19 pm Purchase |
2022-01-11 | 13D | CinCor Pharma, Inc. CINC |
Sofinnova Venture Partners X L.P. | 5,573,949 15.300% |
5,573,949 (New Position) |
Filing |